Leukocare AG:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Leukocare AG - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10388
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Leukocare AG (Leukocare) is a clinical-stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company’s services include development of spray drying and spray freeze-drying processes, development of individual SPS formulations meeting individual needs of target proteins, and development of customized lyophilization protocols. It also provides coupling of biological compounds to functionalize surfaces, development of vaccine formulation, and establishment of biological readouts. Leukocare offers its services in the areas of biophysics, physiology, biochemistry, pharmacology, immunology, pharmaceutical technology, chemistry and medical engineering, among others. The company provides its services across Germany. Leukocare is headquartered in Munich, Germany.

Leukocare AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Leukocare AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Leukocare AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Leukocare AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Leukocare AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Leukocare AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Leukocare AG, Medical Equipment, Deal Details 10
Venture Financing 10
Leukocare Raises US$4.5 Million In Venture Financing 10
Partnerships 11
Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems 11
Trillium Diagnostics Enters Into Licensing Agreement With Leukocare For Sepsis Dx 12
Scil Proteins Enters into Agreement with LEUKOCARE for Stabilized rhThrombin 13
Leukocare AG – Key Competitors 14
Leukocare AG – Key Employees 15
Leukocare AG – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Other Significant Developments 17
Sep 14, 2017: LEUKOCARE Continues to Expand and Invests in Research and Development 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Leukocare AG, Medical Equipment, Key Facts 2
Leukocare AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Leukocare AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Leukocare AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Leukocare AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Leukocare AG, Deals By Market, 2012 to YTD 2018 8
Leukocare AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Leukocare Raises US$4.5 Million In Venture Financing 10
Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems 11
Trillium Diagnostics Enters Into Licensing Agreement With Leukocare For Sepsis Dx 12
Scil Proteins Enters into Agreement with LEUKOCARE for Stabilized rhThrombin 13
Leukocare AG, Key Competitors 14
Leukocare AG, Key Employees 15

List of Figures
Leukocare AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Leukocare AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Leukocare AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Leukocare AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Leukocare AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Leukocare AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Leukocare AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Leukocare AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Leukocare AG:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grupo Aval Acciones Y Valores Sa
    Grupo Aval Acciones Y Valores Sa - Strategy, SWOT and Corporate Finance Report Summary Grupo Aval Acciones Y Valores Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • PT PLN (Persero)-エネルギー分野:企業M&A・提携分析
    Summary PT PLN (Persero) (PLN) is a state-owned power company that generates, transmits and distributes electricity. It generates power from various sources including coal, natural gas and oil fuel based steam power plants. The company also offers electricity support services such as electricity con …
  • GrowMax Resources Corp (BOE):企業の財務・戦略的SWOT分析
    Summary GrowMax Resources Corp (GrowMax), formerly Americas Petrogas Inc is an oil and gas company that offers exploration and development of conventional and unconventional oil and gas properties in Argentina. The company explores and develops phosphate and potassium-rich brine resources in northwe …
  • Morphotek Inc:企業のM&A・事業提携・投資動向
    Morphotek Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Morphotek Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • A1M Pharma AB (A1M)-製薬・医療分野:企業M&A・提携分析
    Summary A1M Pharma AB (A1M Pharma) develops and commercializes drug candidate for the diagnosis and treatment of pre-eclampsia (pandemic poisoning) and acute renal injury. The company offers ROSgard based on A1M (alpha-1-microglobulin), an endogenous protein with properties that captures and elimina …
  • Reynard Corporation:企業の戦略・SWOT・財務情報
    Reynard Corporation - Strategy, SWOT and Corporate Finance Report Summary Reynard Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Deluxe Corporation:企業の戦略・SWOT・財務分析
    Deluxe Corporation - Strategy, SWOT and Corporate Finance Report Summary Deluxe Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Vinci SA:企業のM&A・事業提携・投資動向
    Vinci SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vinci SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Orsted Salg & Service AS:企業の戦略的SWOT分析
    Orsted Salg & Service AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Senzime AB (SEZI):企業の財務・戦略的SWOT分析
    Summary Senzime AB (Senzime) is a medical device company that develops patient-oriented monitoring systems. The company's product include TetraGraph monitor, CliniSenz analyzer, and Onzurf probe. Its TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients …
  • EXOR SpA:戦略・SWOT・企業財務分析
    EXOR SpA - Strategy, SWOT and Corporate Finance Report Summary EXOR SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Unified Grocers, Inc.:戦略・SWOT・企業財務分析
    Unified Grocers, Inc. - Strategy, SWOT and Corporate Finance Report Summary Unified Grocers, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • BL&H Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary BL&H Co Ltd (BL&H), a subsidiary of STADA Pharmaceuticals (Asia) Ltd is a drug company that manufactures and markets diagnostic test kits and drugs. The company offers products including aridol bronchial challenge test kit, cetraxal plus ear drop, al-sense amniotic leak test kit, DC bead-dru …
  • Anaconda Mining Inc:企業の戦略・SWOT・財務分析
    Anaconda Mining Inc - Strategy, SWOT and Corporate Finance Report Summary Anaconda Mining Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Atriva Therapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Atriva Therapeutics GmbH (Atriva Therapeutics) is a developer of antiviral therapies that develops therapies against seasonal and pandemic influenza. The company develops ATR-001 drug candidate, a MEK inhibitor which targets influenza. It also offers repurposing existing MEK inhibitors, orig …
  • Accenture plc:企業の戦略・SWOT・財務情報
    Accenture plc - Strategy, SWOT and Corporate Finance Report Summary Accenture plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Custodian & Allied Plc:企業の戦略・SWOT・財務分析
    Custodian & Allied Plc - Strategy, SWOT and Corporate Finance Report Summary Custodian & Allied Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Teradata Corp (TDC):企業の財務・戦略的SWOT分析
    Teradata Corp (TDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • SDX Energy Inc (SDX):石油・ガス:M&Aディール及び事業提携情報
    Summary SDX Energy Inc (SDX), formerly Sea Dragon Energy Inc., is an independent upstream company. It carries out the exploration, development and production of crude oil and natural gas liquids. The company’s primary areas of focus are Morocco and Egypt. Its principal operations are currently conce …
  • The AES Corporation:発電所・企業SWOT分析
    The AES Corporation – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆